What are the Therapeutic Implications of Targeting IGF Signaling in Cancer?
Targeting IGF signaling represents a promising therapeutic strategy in cancer treatment. Several approaches are being explored, including the development of IGF-1R antagonists, IGF-lowering agents, and IGFBP mimetics. These therapies aim to disrupt the IGF signaling pathways that contribute to tumor growth and survival. Clinical trials are ongoing to evaluate the efficacy and safety of these treatments in various cancer types.
